Hair Loss Litigation

Taxotere (docetaxel) is a kind of taxol (paclitaxel), a prescription medicine primarily utilized in the chemotherapy treatment of women with cancer impacting the breasts, lungs, skin and stomach.

Unfortunately, treatment with Taxotere may lead to permanent hair loss (alopecia) in as many as 15% of individuals. In the Carse Law Firm, we think it could be noted that the maker had knowledge of the threat but failed to disclose it, or claimed that the baldness would just be temporary.

You can also contact some well-kown taxotere lawsuit to file a report against them, so than other people do not suffer from the same problems.

Taxotere-Hair-Loss

Though some customers may not know whether they had been granted Taxotere, permanent baldness is a very rare complication of cancer therapy.

But today we are learning, for some 5% to 15% of breast cancer sufferers, Taxotere has a troubling, disfiguring side effect: permanent hair loss, also referred to as alopecia.

Maybe even more disturbing, we are learning that for the organization’s own studies were revealing the prospect of permanent baldness for breast cancer sufferers utilizing Taxotere, but retained those studies crucial.

Leave a Reply

Your email address will not be published. Required fields are marked *